Lumida
/CATX
⌘K
Perspective Therapeutics Inc

Perspective Therapeutics Inc

CATX
$2.99USD+1.36%+0.04 today

MARKET CAP

341.0M

P/E (TTM)

FWD P/E

DAY RANGE

$3 – $3

52W RANGE

$2
$6

AI Summary

Stalk
Sell NowHigh

CATX remains in a high-confidence Stage 4 decline, trading below all major moving averages with no active patterns to support a rally. Medium-term bearish structure is intact under a sequence of lower highs and lower lows, and short-term conditions show a lack of upside follow-through into declining EMAs. Execution should focus on selling into any relief rallies around the 9/21 EMA zone. A decisive close and hold above those EMAs would invalidate the bearish bias.

  • Dosed first patient with [212Pb]VMT-α-NET in Phase 1/2a meningioma trial
  • High institutional interest via strong 13F ownership signals hedge fund confidence
  • Earnings yield of -3.57% indicates unprofitable operations
Full analysis →
Insider Trades13 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Nov 13, 2025BuyCATXJonathan Robert HuntChief Accounting Officer11,000$2.03$341.0M-51.46%+52.94%$22.3K+22.54%Sell Now
Mar 28, 2025BuyCATXJohan M. SpoorChief Executive Officer26,676$2.24$341.0M-51.46%+52.94%$59.7K+71.41%Sell Now
Mar 28, 2025BuyCATXJuan GrahamChief Financial Officer33,333$2.25$341.0M-51.46%+52.94%$74.9K+1649.33%Sell Now
Dec 4, 2024BuyCATXJohan M. SpoorCEO8,000$3.77$341.0M-51.46%+52.94%$30.1K+28.31%Sell Now
Nov 25, 2024BuyCATXJonathan Robert HuntChief Financial Officer12,829$3.82$341.0M-51.46%+52.94%$49.0K+8.70%Sell Now
Nov 25, 2024BuyCATXJohan M. SpoorCEO26,500$3.79$341.0M-51.46%+52.94%$100.5K+13.41%Sell Now
Jun 17, 2024BuyCATXJonathan Robert HuntChief Financial Officer1,800$9.81$341.0M-51.46%+52.94%$17.7K+5.27%Sell Now
Jun 13, 2024BuyCATXJohan M. SpoorCEO100,000$1.17$341.0M-51.46%+52.94%$117.4K+266.16%Sell Now
May 31, 2024BuyCATXJonathan Robert HuntChief Financial Officer25,006$1.40$341.0M-51.46%+52.94%$35.0K+3.87%Sell Now
Apr 23, 2024BuyCATXMark John AustinVP Finance/Prin Fin&Acct Offic30,000$0.36$341.0M-51.46%+52.94%$10.8K+17.24%Sell Now
Jan 24, 2024BuyCATXMarkus PuhlmannChief Medical Officer280,000$0.50$341.0M-51.46%+52.94%$139.9K+25.56%Sell Now
Dec 18, 2023BuyCATXJonathan Robert HuntChief Financial Officer125,000$0.26$341.0M-51.46%+52.94%$32.3K+65.20%Sell Now
Dec 15, 2023BuyCATXMarkus PuhlmannChief Medical Officer595,425$0.32$341.0M-51.46%+52.94%$188.7K+32.53%Sell Now